{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03757",
    "Peptide Name": "BMAP-28-(1-18) (Synthetic AMPs, N-terminal fragment of BMAP-28, XXA, UCLL1c; BBMm)",
    "Source": "Sequence truncation, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "GGLRSLGRKILRAWKKYG",
    "Sequence Length": 18,
    "UniProt Entry": "",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal",
      "candidacidal",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "2NDC",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 7,
    "Boman Index": 2.07,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "33%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals this sequence is most similar (66.67%) tosynthetic SMAP-18G: 22%; L=K=R: 17%. GRAVY: -0.67; M Wt: 2059.483; M formula: C94H160N31O21; Mol ex coeff: 7040.Activity: Active against E. coli ATCC 25922 ML-35 or D21 (MIC 0.5-1 uM), S. typhimurium ATCC 14028 (MIC 2 uM), P. aeruginosa ATCC 27853 (MIC 1 uM), S. marcescens ATCC 8100 (MIC 2 uM), S. aureus ATCC 25923  Cowan 1 or MRSA (MIC 2-4 uM), S. epidermidis ATCC 12228 (MIC 1 uM), B. megaterium Bm11 (MIC 2 uM), C. albicans (MIC 16 uM), and C. neoformans (MIC 2 uM).Toxicity: Hemolysis is much reduced compared to the parent peptide.Structure: Helical in TFE (CD). NMR found a helical region in the central region in SDS micelles.You can rotate, zoom, and view the 3D structureherein the PDB. Updated 11/2023",
    "Author": "Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M. 1996",
    "Reference": "J Biol Chem. 1996 Nov 8;271(45):28375-81. doi: 10.1074/jbc.271.45.28375.8910461.",
    "Title": "Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities"
  },
  "3D Structure": []
}